Estimating the infection fatality rate of emerging diseases using a regression approach applied to global COVID-19 cases.

Publication date: May 31, 2025

Estimating the infection fatality rate (IFR) for emerging diseases is elusive due to the presence of asymptomatic or mildly symptomatic infections and variable testing capacity. IFR estimates are also affected by region-specific differences in sampling regimes, demographics, and healthcare resources. Here we present a novel regression approach using population testing and readily available case fatality rates (CFR) to estimate the IFR during an outbreak. The approach is based on few assumptions and can be used for a wide range of emerging diseases. We validate the use of the method using commonly reported COVID-19 testing data. Our new statistical approach reveals a conservative global IFR of 0. 90 % (CI: 0. 70 %, 1. 16 %) for COVID-19 across the 139 countries affected before May 2020. Deviation of countries’ reported CFR from the estimator did not correlate with demography, per capita GDP, or healthcare access and quality, suggesting variation is due to differing testing regimes or reporting guidelines by country. This method can be used retrospectively or for future disease outbreaks when other data are limited.

Semantics

Original Article